Pharma Newsletter – September 4 to September 8, 2017

This week, “The share of Cadila Healthcare surged by over 3% intraday during Thursday’s trading session after hat the company informed that USFDA has completed the inspection of its Moraiya facility.”

Sep 09, 2017 09:09 IST India Infoline News Service

Top news:
 
USFDA completes inspection of Cadila Healthcare’s Moraiya unit

The share of Cadila Healthcare surged by over 3% intraday during Thursday’s trading session after hat the company informed that USFDA has completed the inspection of its Moraiya facility. Read more
 
Dr. Reddy Lab launches Metaxalone tablets in US
 
Pharma major, Dr. Reddy Laboratories announced that it has received the US Food and Drug Administration (USFDA) approval to market Metaxalone tablets, USP 800 mg, the company informed in the filing to the bourses on Wednesday. Read more
 
JDRF supports Biocon study of type 1 diabetes treatment
 
Asia’s premier biopharmaceuticals company, and JDRF, the leading global organization funding type 1 diabetes (T1D) research and advocacy worldwide, jointly announced a JDRF partnership to support a global multiple ascending dose study with a novel oral insulin drug candidate, Insulin Tregopil, in people with T1D.Read more

Related Story